Psychiatric Disorders Related to Diabetes Mellitus Type 1

Psychiatric Disorders Related to Diabetes Mellitus Type 1 Among Adolescents in Egypt

The most common endocrine illness in children and adolescents is type 1 diabetes. It is distinguished by a lack of insulin synthesis and necessitates daily insulin injections to keep glucose levels under control. As a result, there are numerous medical approaches to its management, such as levels of glycosylated haemoglobin (HbA1c) as a marker of glycemic control during the previous three months and monitoring of blood glucose levels, which affect the patient's mental health and quality of life. Type 1 diabetes complications and poor quality of life are widespread. Diabetes therapy is difficult during puberty and adolescence. Adolescents with T1D have poor metabolic control and a higher rate of acute complications. Because the onset of adolescence is frequently associated with decreased adherence to therapy and an increased risk of psychological illnesses.

Study Overview

• Status: Not yet recruiting
• Conditions: Adolescents; Psychiatric Disorders; Diabetes Mellitus Type 1
• Intervention / Treatment: Behavioral: diabetes mellitus type 1

• Study Type: Observational
• Enrollment (Anticipated): 140

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 10 years to 19 years (ADULT, CHILD)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

This study will be screening for adolescents with diabetes mellitus

Description

Inclusion Criteria:

1. Both males and females were included.
2. Age ranges from 10 to 19 years.
3. Willing of the parents or the caregivers to participate in the study.
4. Duration of T1DM of at least 1 year.

Exclusion Criteria

1. Adolescents with an intelligence quotient below 70.
2. Adolescents with a history of substance use or psychiatric disorders.
3. Adolescents with medical or other neurological conditions.

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
Measure frequency of sleep problems with diabetes mellitus type 1	through study completion, an average of 1 year
Measures frequency of psychiatric problems with diabetes mellitus type 1	through study completion, an average of 1 year

Collaborators and Investigators

• Sponsor: Assiut University

Study record dates

Study Major Dates

• Study Start (ANTICIPATED): August 1, 2022
• Primary Completion (ANTICIPATED): December 1, 2023
• Study Completion (ANTICIPATED): December 1, 2025

Study Registration Dates

• First Submitted: July 22, 2022
• First Submitted That Met QC Criteria: July 25, 2022
• First Posted (ACTUAL): July 28, 2022

Study Record Updates

• Last Update Posted (ACTUAL): July 28, 2022
• Last Update Submitted That Met QC Criteria: July 25, 2022
• Last Verified: July 1, 2022

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Behavioral Symptoms; Glucose Metabolism Disorders; Metabolic Diseases; Immune System Diseases; Autoimmune Diseases; Endocrine System Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 1; Problem Behavior; Mental Disorders
• Other Study ID Numbers: Diabetes mellitus

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No